Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 76 Pages
Report ld: 3789329
Request Sample
Customized Report
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
The North America Semi-Solid Dose market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Semi-Solid Dose include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Semi-Solid Dose market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Semi-Solid Dose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Semi-Solid Dose in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Semi-Solid Dose manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Semi-Solid Dose revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Semi-Solid Dose Product Scope
1.2 Semi-Solid Dose by Type
1.2.1 Global Semi-Solid Dose Sales by Type (2020 & 2024 & 2031)
1.2.2 Ointments
1.2.3 Pastes
1.2.4 Gels
1.3 Semi-Solid Dose by Application
1.3.1 Global Semi-Solid Dose Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Global Semi-Solid Dose Market Estimates and Forecasts (2020-2031)
1.4.1 Global Semi-Solid Dose Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Semi-Solid Dose Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Semi-Solid Dose Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Semi-Solid Dose Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Semi-Solid Dose Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Semi-Solid Dose Sales Market Share by Region (2020-2025)
2.2.2 Global Semi-Solid Dose Revenue Market Share by Region (2020-2025)
2.3 Global Semi-Solid Dose Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Semi-Solid Dose Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Semi-Solid Dose Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Semi-Solid Dose Market Size and Prospective (2020-2031)
2.4.2 Europe Semi-Solid Dose Market Size and Prospective (2020-2031)
2.4.3 China Semi-Solid Dose Market Size and Prospective (2020-2031)
2.4.4 Japan Semi-Solid Dose Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Semi-Solid Dose Historic Market Review by Type (2020-2025)
3.1.1 Global Semi-Solid Dose Sales by Type (2020-2025)
3.1.2 Global Semi-Solid Dose Revenue by Type (2020-2025)
3.1.3 Global Semi-Solid Dose Price by Type (2020-2025)
3.2 Global Semi-Solid Dose Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Semi-Solid Dose Sales Forecast by Type (2026-2031)
3.2.2 Global Semi-Solid Dose Revenue Forecast by Type (2026-2031)
3.2.3 Global Semi-Solid Dose Price Forecast by Type (2026-2031)
3.3 Different Types Semi-Solid Dose Representative Players
4 Global Market Size by Application
4.1 Global Semi-Solid Dose Historic Market Review by Application (2020-2025)
4.1.1 Global Semi-Solid Dose Sales by Application (2020-2025)
4.1.2 Global Semi-Solid Dose Revenue by Application (2020-2025)
4.1.3 Global Semi-Solid Dose Price by Application (2020-2025)
4.2 Global Semi-Solid Dose Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Semi-Solid Dose Sales Forecast by Application (2026-2031)
4.2.2 Global Semi-Solid Dose Revenue Forecast by Application (2026-2031)
4.2.3 Global Semi-Solid Dose Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Semi-Solid Dose Application
5 Competition Landscape by Players
5.1 Global Semi-Solid Dose Sales by Players (2020-2025)
5.2 Global Top Semi-Solid Dose Players by Revenue (2020-2025)
5.3 Global Semi-Solid Dose Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Dose as of 2024)
5.4 Global Semi-Solid Dose Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Semi-Solid Dose, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Semi-Solid Dose, Product Type & Application
5.7 Global Key Manufacturers of Semi-Solid Dose, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Semi-Solid Dose Sales by Company
6.1.1.1 North America Semi-Solid Dose Sales by Company (2020-2025)
6.1.1.2 North America Semi-Solid Dose Revenue by Company (2020-2025)
6.1.2 North America Semi-Solid Dose Sales Breakdown by Type (2020-2025)
6.1.3 North America Semi-Solid Dose Sales Breakdown by Application (2020-2025)
6.1.4 North America Semi-Solid Dose Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Semi-Solid Dose Sales by Company
6.2.1.1 Europe Semi-Solid Dose Sales by Company (2020-2025)
6.2.1.2 Europe Semi-Solid Dose Revenue by Company (2020-2025)
6.2.2 Europe Semi-Solid Dose Sales Breakdown by Type (2020-2025)
6.2.3 Europe Semi-Solid Dose Sales Breakdown by Application (2020-2025)
6.2.4 Europe Semi-Solid Dose Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Semi-Solid Dose Sales by Company
6.3.1.1 China Semi-Solid Dose Sales by Company (2020-2025)
6.3.1.2 China Semi-Solid Dose Revenue by Company (2020-2025)
6.3.2 China Semi-Solid Dose Sales Breakdown by Type (2020-2025)
6.3.3 China Semi-Solid Dose Sales Breakdown by Application (2020-2025)
6.3.4 China Semi-Solid Dose Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Semi-Solid Dose Sales by Company
6.4.1.1 Japan Semi-Solid Dose Sales by Company (2020-2025)
6.4.1.2 Japan Semi-Solid Dose Revenue by Company (2020-2025)
6.4.2 Japan Semi-Solid Dose Sales Breakdown by Type (2020-2025)
6.4.3 Japan Semi-Solid Dose Sales Breakdown by Application (2020-2025)
6.4.4 Japan Semi-Solid Dose Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Johnson & Johnson Semi-Solid Dose Products Offered
7.1.5 Johnson & Johnson Recent Development
7.2 Merck & Co
7.2.1 Merck & Co Company Information
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck & Co Semi-Solid Dose Products Offered
7.2.5 Merck & Co Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Company Information
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bayer AG Semi-Solid Dose Products Offered
7.3.5 Bayer AG Recent Development
7.4 Hisamitsu Pharmaceutical
7.4.1 Hisamitsu Pharmaceutical Company Information
7.4.2 Hisamitsu Pharmaceutical Business Overview
7.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Hisamitsu Pharmaceutical Semi-Solid Dose Products Offered
7.4.5 Hisamitsu Pharmaceutical Recent Development
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Company Information
7.5.2 Glenmark Pharmaceuticals Business Overview
7.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Glenmark Pharmaceuticals Semi-Solid Dose Products Offered
7.5.5 Glenmark Pharmaceuticals Recent Development
7.6 Cipla Ltd
7.6.1 Cipla Ltd Company Information
7.6.2 Cipla Ltd Business Overview
7.6.3 Cipla Ltd Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Cipla Ltd Semi-Solid Dose Products Offered
7.6.5 Cipla Ltd Recent Development
7.7 Nestle SA
7.7.1 Nestle SA Company Information
7.7.2 Nestle SA Business Overview
7.7.3 Nestle SA Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Nestle SA Semi-Solid Dose Products Offered
7.7.5 Nestle SA Recent Development
7.8 Novartis AG
7.8.1 Novartis AG Company Information
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Novartis AG Semi-Solid Dose Products Offered
7.8.5 Novartis AG Recent Development
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Information
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.9.4 GlaxoSmithKline plc Semi-Solid Dose Products Offered
7.9.5 GlaxoSmithKline plc Recent Development
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Company Information
7.10.2 Bausch Health Companies Business Overview
7.10.3 Bausch Health Companies Semi-Solid Dose Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Bausch Health Companies Semi-Solid Dose Products Offered
7.10.5 Bausch Health Companies Recent Development
8 Semi-Solid Dose Manufacturing Cost Analysis
8.1 Semi-Solid Dose Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Semi-Solid Dose
8.4 Semi-Solid Dose Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Semi-Solid Dose Distributors List
9.3 Semi-Solid Dose Customers
10 Semi-Solid Dose Market Dynamics
10.1 Semi-Solid Dose Industry Trends
10.2 Semi-Solid Dose Market Drivers
10.3 Semi-Solid Dose Market Challenges
10.4 Semi-Solid Dose Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 130
USD 2900.00
(Single User License)
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 142
USD 4900.00
(Single User License)
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 99
USD 3950.00
(Single User License)
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-02-14
Pages: 98
USD 2900.00
(Single User License)
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-01-04
Pages: 130
USD 3950.00
(Single User License)
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 105
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 130
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 142
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 99
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 94
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-04-10
Pages: 112
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-02-14
Pages: 98
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-01-04
Pages: 130
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now